Randi Schwartz Patient

Randi, an incredible athlete, was training for her first IRONMAN and did not feel as strong as she thought she should. A trip to the doctor helped her understand why: She had cancer. After a stem cell transplant and treatment, she wanted to try to get back to doing what she loved, and decided to join the MMRF’s inaugural Road to Victories team. She was one of 20 people who rode the first leg of the cross country inaugural ride, enduring long hot days through the Mojave and Sonora Deserts, followed by grueling climbs up the mountains of Arizona to Flagstaff,. The following year, Randi joined her R2V teammate and fellow myeloma patient Carmen Phaneuf as part of an Ironman Relay in Lake Placid, NY. Randi also gathers her friends and fellow triathletes in her local community of Ft. Lauderdale each year to come together as a community as part of the MMRF Team for Cures 5K Walk/Run event. Randi is a force of nature and an inspiration to all. She is an incredible addition to this team as she shows that a diagnosis does not need to stop you from being active.Her positivity and attitude is contagious!

A Mission. A Celebration. A call to fear-less, love more and live generously!
Randi Schwartz
There is not a second that I take that for granted. So I want to live big and make a big difference doing it! This ride is about making each…
Read More
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More